Expanding life sciences sector drives deal surge

SYDNEY: Life sciences hubs are driving demand for real estate as the once-niche ... read more

Mesoblast set to line up another FDA chat

MELBOURNE: Shares in stem cell treatments developer Mesoblast opened 3 per cent higher ... read more

Crescent seeks buyer for clinical trials biz Nucleus

MELBOURNE: Australian private equity firm Crescent Capital Partners has put its clinical research ... read more

Hostplus announces board shakeup in A.S.X. news release

AUCKLAND: Three board members of the industry superannuation fund have been replaced after ... read more